Objective SCHISTOSOMIASIS ,CAUSED BY PARASITIC HELMINTHS OF THE GENUS SCHISTOSOMA, AFFLICTS APPROXIMATELY 200 MILLION PEOPLE WORLDWIDE.IN BRAZIL AROUND 10 MILLION PEOPLE ARE INFECTED OR AT RISK.CONTROL MEASURE, INCLUDING THE USE OF MOLLUCICIDES TO KILL THE SNAIL VECTOR,AND MASS CHEMOTHERAPYOF THE HUMAN POPULATION ,HAVE BEEN WIDELY APPLIED BUT WITH LIMITED SUCCESS.THE PATOLOGICAL DAMAGE WHICH RESULTS FROM INFECTION IS A MAJOR PROBLEM,OCCURRING IN AS MUCH AS 20% OF THE INFECTED POPULATION IN BRAZIL.PREVENTION OF INFECTION BY EFFECTIVE VACCINATION WOULD AVOID THESE COMPLICATIONS AND WOULD ALSO DECREASE TRANSMISSION IN ENDEMIC AREAS.THE LONG TERM OBJECTIVE OF OUR RESEARCH IS TO DEVELOP SUCH A VACCINE. Fields of science medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsvaccines Programme(s) FP3-STD 3 - Specific research and technological development programme (EEC) in the field of the life sciences and technologies for developing countries, 1990-1994 Topic(s) Data not available Call for proposal Data not available Funding Scheme CSC - Cost-sharing contracts Coordinator UNIVERSITY OF YORK Address Heslington York United Kingdom See on map Links Website Opens in new window EU contribution € 0,00 Participants (2) Sort alphabetically Sort by EU Contribution Expand all Collapse all FUNDACAO OSWALDO CRUZ - MINISTERIO DA SAUDE Brazil EU contribution € 0,00 Address 1715,av. augusto de lima 1715 30190-002 Belo horizonte See on map Institut Pasteur de Lille France EU contribution € 0,00 Address 1 rue du professeur albert calmette 59019 Lille See on map
